Vaccine News and Research

Latest Vaccine News and Research

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

NHS patients are set to benefit from cutting-edge new treatments and technologies as the government introduces a Vaccine Taskforce style approach to tackling some of the biggest public health challenges facing the UK.

27 Nov 2022

Scientists develop preclinical model of scrub typhus disease

Scientists have developed an animal model of scrub typhus using outbred CD-1 mice. Using the model, they have characterized host susceptibility to the causative pathogen, disease pathogenesis, and immune responses. The study has been published in the journal PLOS Neglected Tropical Diseases.

27 Nov 2022

All trimesters of pregnancy carry the same COVID-19 risk

A study in the American Journal of Obstetrics & Gynecology MFM journal aimed to analyze the effect of the trimester of SARS-CoV-2 infection on the progression of the disease in pregnant women.

27 Nov 2022

Boosting Africa's capacity to manufacture vaccines

Africa produces only one per cent of its routine vaccines. This leaves the region dependent on imports for its vaccine needs, and makes it vulnerable to a vaccine crisis during health emergencies.

25 Nov 2022

Multivalent mRNA-based vaccine may serve as a preventative measure against future flu pandemics

An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve one day as a general preventative measure against future flu pandemics, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

25 Nov 2022

New approach may serve as the basis for universal flu vaccines

Claudia Arevalo and colleagues have developed a mRNA lipid nanoparticle vaccine that contains antigens from all 20 known subtypes of influenza A and B viruses, a strategy that may serve as the basis for universal flu vaccines.

24 Nov 2022

All eligible people urged to get vaccinated due to higher rates of flu cases than usual

All those eligible for the flu vaccine have been urged to come forward as cases rise to levels not seen since before the pandemic.

24 Nov 2022

AI helps design synthetic DNA that controls cells' protein production

With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells' protein production.

24 Nov 2022

What was the return on investment of the COVID-19 vaccination campaign in New York City?

A recent study estimated the return on investment (ROI) of New York City’s coronavirus disease 2019 (COVID-19) vaccination campaign.

24 Nov 2022

Do previously infected individuals still benefit from vaccination against COVID-19?

Researchers determined the vaccine effectiveness (VE) of the primary coronavirus disease 2019 (COVID-19) vaccination series.

24 Nov 2022

The relationship between neutralization levels and observed efficacies against asymptomatic and symptomatic infection of ten COVID-19 vaccines

Researchers determined whether neutralizing antibody levels were predictive of the efficacy of fractional vaccine doses against SARS-CoV-2 infection.

24 Nov 2022

Study highlights global estimates of mortality related to 33 clinically significant bacterial pathogens

Researchers presented comprehensive global estimates of the mortality burden related to 33 species or genera of bacterial pathogenic organisms causing 11 main infectious syndromes in 2019 using data and methods of the GBD 2019 and the global burden of antimicrobial resistance study conducted in the same year.

24 Nov 2022

Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

Researchers assessed the association between receiving a prescription for Paxlovid and COVID-19-related hospitalization in the ensuing 30 days.

24 Nov 2022

COVID-19 disparities more likely to negatively impact Black and Hispanic men

More than two years into the pandemic, multiple analyses of federal, state and local data show that people of color were, and continue to be, disproportionately impacted by COVID-19.

23 Nov 2022

COVID-19 vaccination provides 60% to 94% protection against reinfection

Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant.

23 Nov 2022

Bivalent mRNA vaccines could enhance protective efficacy against COVID-19

A new study presents evidence suggestive of restored or increased efficacy from changing the formulation of COVID-19 vaccines to a bivalent one.

23 Nov 2022

How did population immunity against SARS-CoV-2 infection and subsequent severe disease change between December 2021 and November 2022?

Researchers explored the alterations in population immunity against SARS-CoV-2 Omicron variant infection and severe disease.

23 Nov 2022

The safety and immunogenicity of a fourth dose of NVX-CoV2373

Researchers assessed the immunogenicity and safety of a fourth homologous boost dose of a recombinant SARS-CoV-2 spike protein vaccine called NVX-CoV2373.

23 Nov 2022

The binding and functional serologic responses to COVID-19 vaccination in children with history of MIS-C

Researchers evaluated the serological responses elicited by COVID-19 vaccinations in children who developed MIS-C following a previous SARS-CoV-2 infection.

23 Nov 2022

Myocarditis after COVID vaccination is rare but higher in younger males

In a recent study published in the Canadian Medical Association Journal, researchers observed the incidence of myocarditis following messenger ribonucleic acid (mRNA)-based vaccination against coronavirus disease 2019 (COVID-19). Additionally, they compared their estimates with expected rates based on the historical rates assessed before the COVID-19 vaccination rollout in British Columbia (BC), Canada.

22 Nov 2022

Vaccine News and Research

Latest Vaccine News and Research

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

Scientists develop preclinical model of scrub typhus disease

All trimesters of pregnancy carry the same COVID-19 risk

Boosting Africa's capacity to manufacture vaccines

Multivalent mRNA-based vaccine may serve as a preventative measure against future flu pandemics

New approach may serve as the basis for universal flu vaccines

All eligible people urged to get vaccinated due to higher rates of flu cases than usual

AI helps design synthetic DNA that controls cells' protein production

What was the return on investment of the COVID-19 vaccination campaign in New York City?

Do previously infected individuals still benefit from vaccination against COVID-19?

The relationship between neutralization levels and observed efficacies against asymptomatic and symptomatic infection of ten COVID-19 vaccines

Study highlights global estimates of mortality related to 33 clinically significant bacterial pathogens

Study demonstrates that Paxlovid protects severe COVID-19–associated outcomes among persons for whom it is recommended

COVID-19 disparities more likely to negatively impact Black and Hispanic men

COVID-19 vaccination provides 60% to 94% protection against reinfection

Bivalent mRNA vaccines could enhance protective efficacy against COVID-19

How did population immunity against SARS-CoV-2 infection and subsequent severe disease change between December 2021 and November 2022?

The safety and immunogenicity of a fourth dose of NVX-CoV2373

The binding and functional serologic responses to COVID-19 vaccination in children with history of MIS-C

Myocarditis after COVID vaccination is rare but higher in younger males

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in